1. Is Neuland Laboratories Ltd a good quality company?
Past 10 year’s financial track record analysis by Moneyworks4me indicates that Neuland Laboratories Ltd is a below average quality company.
2. Is Neuland Laboratories Ltd undervalued or overvalued?
The key valuation ratios of Neuland Laboratories Ltd's currently when compared to its past seem to suggest it is in the Fair zone.
3. Is Neuland Laboratories Ltd a good buy now?
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Neuland Laboratories Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
Value Creation ⓘ
Value Creation Index Colour Code Guide ⓘ
|ROCE % ⓘ||12.3%||14.9%||10.8%||12.1%||11.2%||3.2%||3.4%||3.4%||8.9%||7.4%||-|
|Value Creation Index ⓘ||-0.1||0.1||-0.2||-0.1||-0.2||-0.8||-0.8||-0.8||-0.4||-0.5||-|
Growth Parameters ⓘ
Growth Parameters Colour Code Guide ⓘ
|YoY Gr. Rt. %||-||1.1%||0.7%||8.7%||13.5%||-8.9%||26.4%||14.4%||22.8%||1.5%||-|
|Adj EPS ⓘ||19||36.5||18.5||29.3||53.1||13.8||15.5||13.1||56.8||50.6||50.5|
|YoY Gr. Rt. %||-||92.3%||-49.2%||58.1%||81%||-73.9%||11.9%||-15.5%||334%||-10.9%||-|
|BVPS (₹) ⓘ||121.8||151.8||179||206.3||260||273.5||541.5||549.2||608.7||650.6||658.2|
|Adj Net Profit ⓘ||15.2||29.3||16.5||26.1||47.2||12.3||19.9||16.8||72.8||64.9||65|
|Cash Flow from Ops. ⓘ||26.2||48.5||13.1||44.7||38.9||11.5||69.6||56.6||189||58.6||-|
|Debt/CF from Ops. ⓘ||8.1||3.9||14.4||4.1||4.9||27.7||3.3||4.6||0.9||3.9||-|
CAGR Colour Code Guide ⓘ
|9 Years||5 Years||3 Years||1 Years|
|Adj EPS ⓘ||11.5%||-1%||48.4%||-10.9%|
Key Financial Parameters ⓘ
Performance Ratio Colour Code Guide ⓘ
|Return on Equity % ⓘ||17.5||26.5||11.7||15.1||13||2.2||3.2||2.4||9.8||8||7.7|
|Op. Profit Mgn % ⓘ||13.2||15.9||14.4||15.7||18.5||9.6||9.5||13.5||15.9||15.2||14.7|
|Net Profit Mgn % ⓘ||3.3||6.3||3.5||5.1||8.2||2.3||3||2.2||7.8||6.8||6.7|
|Debt to Equity ⓘ||2.2||1.6||1.2||1||0.8||1.3||0.3||0.4||0.2||0.3||-|
|Working Cap Days ⓘ||187||211||244||233||220||284||242||225||207||218||0|
|Cash Conv. Cycle ⓘ||60||73||82||87||106||152||121||116||106||124||0|
Return on Equity has increased versus last 3 years average to 7.70%
Sales growth is growing at healthy rate in last 3 years 12.56%
Net Profit is growing at healthy rate in last 3 years 48.37%
Sales growth is not so good in last 4 quarters at 4.46%
|TTM EPS (₹)||50.5||50.7|
|TTM Sales (₹ Cr.)||971||971|
|BVPS (₹.) ⓘ||658.2||662.2|
|Reserves (₹ Cr.) ⓘ||832||837|
|From the Market|
|52 Week Low / High (₹)||965.85 / 1875.00|
|All Time Low / High (₹)||14.26 / 2840.00|
|Market Cap (₹ Cr.)||1,765|
|Equity (₹ Cr.)||12.8|
|Face Value (₹)||10|
|Industry PE ⓘ||37.9|
Named after Father Nieuwland of Notre dame, Neuland Laboratories was incorporated in 1984 by Dr. D. R. Rao for the manufacture of Salbutamol Sulphate, with mere 40 employees.
It has started its commercial production of Salbutamol Sulphate in the year 1986. It has since grown to become one of the most reliable API source for Pharma Industry with addition of more products in course of years.
Today the company with a total employee strength of 1000+ is the preferred supplier of APIs with unmatched quality and timely delivery. Neuland is a quality conscious, research driven, reliable source of active pharmaceutical ingredients.
Operating from India for over two decades, Neuland is the preferred source for the Pharmaceutical Industry across the globe, with strengths in Research based Chemistry and Manufacturing.
The Company has started its commercial production of Salbutamol Sulphate in the year 1986. It has since grown to become one of the most reliable API source for Pharma Industry with addition of more products in course of years.Today the company with a total employee strength of 1000+ is the preferred supplier of APIs with unmatched quality and timely delivery.
Neuland has two world-class API manufacturing facilities close to the city of Hyderabad, capable in handling complex and hazardous reactions. Safety aspects have been given utmost significance may it be plant installation, equipment, systems and personnel to ensure smooth productivity. Dedicated team of manufacturing with incorporation of latest production techniques guarantees delivery of latest intermediate and product to our customers across the globe.
Product range of the company includes: